Answers are grounded in this paper and cite their sources.
Since obesity is a chronic, multifaceted, and heterogeneous disease influenced by genetic, biological, and environmental factors, it is imperative to approach obesity with an included and complete treatment strategy. Obesity is one of the resulting causes of morbidity and mortality worldwide, and its incidence is increasing globally. Despite significant advancements in the treatment of obesity-related conditions such as high blood pressure, type 2 diabetes, and high cholesterol, treating obesity itself remains a challenging undertaking. Many antiobesity medications (AOMs) don't work as prescribed, leading to insufficient weight loss and safety concerns. This review investigates the evolution of AOM, highlighting past successes and failings to shed light on contemporary problems. Recent advances, particularly in understanding the molecular dialogue between the gut and brain, offer prospective avenues for the next generation of AOMs. These might hold the key to safely and effectively accomplishing substantial, long-term weight loss
No takes yet. Share an insight, caveat, or question.
Alkhafaji et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: